Back to results
US 2001/0044524 A1Published application
Method for preparing dual virally inactivated immune globulin for intravenous administration
AssigneeAlpha Therapeutic Corporation
InventorsRaja R. Mamidi, Andranik Bagdasarian, Gorgonio Canaveral, Kazuo Takechi
Life of this patent
Estimating the term…
Abstract
A process for producing an intravenously-administrable gamma globulin solution substantially free of contaminating viruses by fractionating an impure gamma globulin solution and then treating the purified gamma globulin, in any order, with a solvent-detergent for viral inactivation and a heat treating for viral inactivation. Thereafter, denatured impurities, residual solvent and aggregate generated by the heat treatment are removed from the gamma globulin.
Claims25
A process for preparing an intravenously administrable gamma globulin solution which comprises:
- (a) subjecting an impure gamma globulin solution to polyethylene glycol fractionation for obtaining a purified gamma globulin;
- (b) treating the polyethylene glycol purified gamma globulin with an organic solvent for inactivating envelope viruses;
- (c) heat treating the polyethylene glycol purified gamma globulin under time and temperature conditions sufficient for inactivating heat sensitive viruses;
- and then
- (d) removing aggregates generated by the heat treatment.
2 more elements
Dependencies are inferred from the claim text.